FDA clears I-ReadMammo

Recognizing that many abnormalities don’t ‘read the textbook,’ we strive to provide the most accurate assessments amid the gray zones of image interpretation.

In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.

State law changes expanding screening mammography coverage from biennial to annual exams and to women 40 years of age in 2019 also led to a 5 percent higher likelihood of screening for Missouri women with commercial health insurance.

In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.

Beyond the hype, whole-body MRI offers limited clinical benefit in the general population with extraneous use potentially triggering a cycle of overdiagnosis, unnecessary treatment and financial strain.

Advanced annotation with the updated UroNav MRI/ultrasound fusion platform may facilitate enhanced precision and efficiency with focal therapies for prostate cancer.